Loading...
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
Natural killer cells (NK) are essential for the elimination of resistant acute myeloid and acute lymphoblastic leukemia (AML and ALL) cells. NK cell-based immunotherapies have already successfully entered for clinical trials, but limitations due to immune escape mechanisms were identified. Therefore...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5596090/ https://ncbi.nlm.nih.gov/pubmed/28943878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01100 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|